Richard George Armitt Couzens
Directeur/Membre du Conseil chez BBI Enzymes (USA) Ltd.
Profil
Richard George Armitt Couzens is currently a Director at BBI Diagnostics Group Ltd., BBI Healthcare Ltd., Eagle SPV 2 Ltd., Eagle SPV 3 Ltd., BBI Group Holding Ltd., BBI Enzymes (USA) Ltd., BBI Resources Ltd., and BBI Group Holdco Ltd.
He previously worked as the Managing Director-Cleaning & Specialist Services at MITIE Group Plc and as a Director at Mitie Compliance Ltd.
Postes actifs de Richard George Armitt Couzens
| Sociétés | Poste | Début |
|---|---|---|
BBI Enzymes (USA) Ltd.
 BBI Enzymes (USA) Ltd. Chemicals: Major DiversifiedProcess Industries Part of Novo Nordisk Fonden, BBI Enzymes (USA) Ltd. is a British company that manufactures chemical products. The company is based in Cardiff, UK. BBI Enzymes (USA was founded in 1985. | Directeur/Membre du Conseil | 27/11/2018 |
Eagle SPV 2 Ltd.
 Eagle SPV 2 Ltd. Financial ConglomeratesFinance Part of Novo Nordisk Fonden, Eagle SPV 2 Ltd. is an investment holding British company. The company is based in Cardiff, UK. Eagle SPV 2 was founded in 2015. | Directeur/Membre du Conseil | 27/11/2018 |
Eagle SPV 3 Ltd.
 Eagle SPV 3 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk Fonden, Eagle SPV 3 Ltd. is a British company that provides professional, scientific and technical services. The company is based in Cardiff, UK. Eagle SPV 3 was founded in 2015. | Directeur/Membre du Conseil | 27/11/2018 |
BBI Resources Ltd.
 BBI Resources Ltd. Personnel ServicesCommercial Services Part of BBI Diagnostics Group Ltd., BBI Resources Ltd. is a staffing services provider. The company is based in Cardiff, UK. BBI Resources was founded in 2013. | Directeur/Membre du Conseil | 01/11/2018 |
BBI Healthcare Ltd.
 BBI Healthcare Ltd. Drugstore ChainsRetail Trade Part of Venture Life Group Plc, BBI Healthcare Ltd. distributes drugs and health supplements. The company is based in Pencoed, UK. The British company was founded in 2005. BBI Healthcare was acquired by Venture Life Group Plc from BBI Diagnostics Group Ltd. on June 07, 2021 for $37.41 million. | Directeur/Membre du Conseil | 27/11/2018 |
BBI Diagnostics Group Ltd.
 BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Directeur/Membre du Conseil | 27/11/2018 |
BBI Group Holding Ltd.
 BBI Group Holding Ltd. Medical DistributorsDistribution Services BBI Group Holding Ltd. develops and distributes diagnostic equipment. The firm offers gold nanoparticles, assay reagents, contract lateral flow test development, human proteins, enzymes, antibodies, gold conjugates, lateral flow assay development, patient samples, disease state plasma, and biobank. The company was founded by John Chandler in 1986 and is headquartered in Crumlin, the United Kingdom. | Directeur/Membre du Conseil | 27/11/2018 |
BBI Group Holdco Ltd.
 BBI Group Holdco Ltd. Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million. | Directeur/Membre du Conseil | 02/06/2020 |
Anciens postes connus de Richard George Armitt Couzens
| Sociétés | Poste | Fin |
|---|---|---|
| MITIE GROUP PLC | Corporate Officer/Principal | 01/11/2017 |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MITIE GROUP PLC | Commercial Services |
| Entreprise privées | 9 |
|---|---|
Mitie Compliance Ltd.
 Mitie Compliance Ltd. Information Technology ServicesTechnology Services Mitie Compliance Ltd. provides nationwide access register services. It services include fire safety, health and safety consultancy, equipment tracking and management, contractor quality audits, non technical building condition audits, disability access audits and communications platforms and marketing platforms. The company was founded on August 27, 2002 and is headquartered in London, the United Kingdom. | Technology Services |
BBI Enzymes (USA) Ltd.
BBI Enzymes (USA) Ltd. Chemicals: Major DiversifiedProcess Industries Part of Novo Nordisk Fonden, BBI Enzymes (USA) Ltd. is a British company that manufactures chemical products. The company is based in Cardiff, UK. BBI Enzymes (USA was founded in 1985. | Process Industries |
Eagle SPV 2 Ltd.
Eagle SPV 2 Ltd. Financial ConglomeratesFinance Part of Novo Nordisk Fonden, Eagle SPV 2 Ltd. is an investment holding British company. The company is based in Cardiff, UK. Eagle SPV 2 was founded in 2015. | Finance |
Eagle SPV 3 Ltd.
Eagle SPV 3 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk Fonden, Eagle SPV 3 Ltd. is a British company that provides professional, scientific and technical services. The company is based in Cardiff, UK. Eagle SPV 3 was founded in 2015. | Commercial Services |
BBI Resources Ltd.
BBI Resources Ltd. Personnel ServicesCommercial Services Part of BBI Diagnostics Group Ltd., BBI Resources Ltd. is a staffing services provider. The company is based in Cardiff, UK. BBI Resources was founded in 2013. | Commercial Services |
BBI Healthcare Ltd.
BBI Healthcare Ltd. Drugstore ChainsRetail Trade Part of Venture Life Group Plc, BBI Healthcare Ltd. distributes drugs and health supplements. The company is based in Pencoed, UK. The British company was founded in 2005. BBI Healthcare was acquired by Venture Life Group Plc from BBI Diagnostics Group Ltd. on June 07, 2021 for $37.41 million. | Retail Trade |
BBI Diagnostics Group Ltd.
BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
BBI Group Holding Ltd.
BBI Group Holding Ltd. Medical DistributorsDistribution Services BBI Group Holding Ltd. develops and distributes diagnostic equipment. The firm offers gold nanoparticles, assay reagents, contract lateral flow test development, human proteins, enzymes, antibodies, gold conjugates, lateral flow assay development, patient samples, disease state plasma, and biobank. The company was founded by John Chandler in 1986 and is headquartered in Crumlin, the United Kingdom. | Distribution Services |
BBI Group Holdco Ltd.
BBI Group Holdco Ltd. Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million. | Health Technology |